Novo Nordisk Biotech Fund has committed EUR 5m to a second closing of a series-B funding round for Affimed Therapeutics AG, bringing the total raised at this stage to EUR 30m.
Software developer, which works on an AI-backed optical character recognition program, is opening a US-based subsidiary
GP plans to form a new care home group with six further facilities bought from Convico
Pantheon offers regional primary fund programmes, secondaries, and co-investment
Portobello Structured Partnership I will target minority stakes in mid-market companies